Suppr超能文献

从圆柏中寻找潜在的神经母细胞瘤治疗药物。

Potential anti-neuroblastoma agents from Juniperus oblonga.

机构信息

School of Pharmaceutical Science and Technology, Health Sciences Platform, Tianjin University, Tianjin, 30072, China.

Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo, Hawaii, 96720, USA.

出版信息

Biochem Biophys Res Commun. 2019 Aug 27;516(3):733-738. doi: 10.1016/j.bbrc.2019.06.123. Epub 2019 Jun 26.

Abstract

Neuroblastoma (NB) is a neuroendocrine tumor derived from neural crest cells. Approximately 90% of cases occur in children less than 5 years old. The amplification of MYCN correlates with high-risk neuroblastoma and patients with MYCN amplified showed poorer prognosis than those without MYCN amplification. In this study, three compounds isolated from Juniperus oblonga showed anti-proliferative activity against NB cell lines with and without tetracycline inducible MYCN over-expression which were identified as (-)-deoxypodophyllotoxin (1), (-)-matairesinol (2) and (+)-isocupressic acid (3). The effects of compounds 2 and 3 in NB cells included a decrease in NB cell viability and induction of apoptosis. Compound 1 was more effective in NB cells over-expressing MycN. Compound 1 also showed almost 2-fold induction of intracellular free calcium levels in M2(+) cells, which may indicate a different mechanism of action for this compound. Cytotoxicity studies against the human embryonic kidney cell (HEK-293) showed compounds 1, 2 and 3 were ineffective in the non-cancer cells at concentrations approximating their IC against the NB cell lines. These results may lead to safer and more effective treatment options for NB patients especially for those with high-risk NB.

摘要

神经母细胞瘤(NB)是一种起源于神经嵴细胞的神经内分泌肿瘤。大约 90%的病例发生在 5 岁以下的儿童中。MYCN 的扩增与高危神经母细胞瘤相关,与没有 MYCN 扩增的患者相比,具有 MYCN 扩增的患者预后更差。在这项研究中,从圆柏中分离出的三种化合物对具有和没有四环素诱导的 MYCN 过表达的 NB 细胞系显示出抗增殖活性,它们被鉴定为(-)-脱氧鬼臼毒素(1)、(-)-马兜铃内脂(2)和(+)-异贝壳杉烯酸(3)。化合物 2 和 3 在 NB 细胞中的作用包括降低 NB 细胞活力和诱导细胞凋亡。化合物 1 在过表达 MycN 的 NB 细胞中更有效。化合物 1 还在 M2(+)细胞中几乎诱导了 2 倍的细胞内游离钙水平增加,这可能表明该化合物的作用机制不同。对人胚肾细胞(HEK-293)的细胞毒性研究表明,化合物 1、2 和 3 在接近其对 NB 细胞系的 IC 的浓度下对非癌细胞无效。这些结果可能为 NB 患者,特别是高危 NB 患者提供更安全、更有效的治疗选择。

相似文献

1
Potential anti-neuroblastoma agents from Juniperus oblonga.
Biochem Biophys Res Commun. 2019 Aug 27;516(3):733-738. doi: 10.1016/j.bbrc.2019.06.123. Epub 2019 Jun 26.
2
Evaluation of Rhodiola crenulata on growth and metabolism of NB-1691, an MYCN-amplified neuroblastoma cell line.
Tumour Biol. 2018 Jun;40(6):1010428318779515. doi: 10.1177/1010428318779515.
3
Deoxypodophyllotoxin isolated from Juniperus communis induces apoptosis in breast cancer cells.
Anticancer Agents Med Chem. 2015;15(1):79-88. doi: 10.2174/1871520614666140608150448.
4
Anti-mycobacterial natural products from the Canadian medicinal plant Juniperus communis.
J Ethnopharmacol. 2012 Sep 28;143(2):695-700. doi: 10.1016/j.jep.2012.07.035. Epub 2012 Aug 1.
5
Transcript signatures that predict outcome and identify targetable pathways in MYCN-amplified neuroblastoma.
Mol Oncol. 2016 Nov;10(9):1461-1472. doi: 10.1016/j.molonc.2016.07.012. Epub 2016 Aug 18.
9
Targeted MYCN expression affects cytotoxic potential of chemotherapeutic drugs in neuroblastoma cells.
Cancer Lett. 2007 May 18;250(1):17-24. doi: 10.1016/j.canlet.2006.09.010. Epub 2006 Dec 4.
10
A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma.
Cancer Res. 2019 Dec 15;79(24):6166-6177. doi: 10.1158/0008-5472.CAN-19-0008. Epub 2019 Oct 15.

引用本文的文献

1
Lactoferrin inhibits the proliferation of IMR‑32 neuroblastoma cells even under X‑rays.
Med Int (Lond). 2023 Jun 26;3(4):33. doi: 10.3892/mi.2023.93. eCollection 2023 Jul-Aug.

本文引用的文献

1
2
Emerging drugs for neuroblastoma.
Expert Opin Emerg Drugs. 2013 Jun;18(2):155-71. doi: 10.1517/14728214.2013.796927. Epub 2013 May 22.
3
The genetic landscape of high-risk neuroblastoma.
Nat Genet. 2013 Mar;45(3):279-84. doi: 10.1038/ng.2529. Epub 2013 Jan 20.
4
Flavonoid composition of Juniperus oblonga Bieb.
Bull Exp Biol Med. 2011 Apr;150(6):714-7. doi: 10.1007/s10517-011-1231-1.
5
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.
J Clin Oncol. 2009 Jan 10;27(2):289-97. doi: 10.1200/JCO.2008.16.6785. Epub 2008 Dec 1.
6
Neuroblastoma.
Lancet. 2007 Jun 23;369(9579):2106-20. doi: 10.1016/S0140-6736(07)60983-0.
7
Sulforhodamine B colorimetric assay for cytotoxicity screening.
Nat Protoc. 2006;1(3):1112-6. doi: 10.1038/nprot.2006.179.
9
Chromosome 1p and 11q deletions and outcome in neuroblastoma.
N Engl J Med. 2005 Nov 24;353(21):2243-53. doi: 10.1056/NEJMoa052399.
10
Sphingolipids in neuroblastoma: their role in drug resistance mechanisms.
Neurochem Res. 2002 Aug;27(7-8):665-74. doi: 10.1023/a:1020228117739.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验